GDRX · GoodRx Holdings, Inc. · Documents

Nov 9

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $187.32M ▼ 4.0% Net loss $41.73M Diluted EPS -$0.10

Nov 8

Earnings call

Q3 2022 earnings call

Nov 8

Current report 8-K

Financial results

Sep 26

Current report 8-K Events of Sep 22

Director or officer change, or executive pay

Aug 31

Current report 8-K Events of Aug 30

Exit or restructuring costs

Aug 9

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $191.8M ▲ 8.6% Net loss $1.42M Diluted EPS $0.00

Aug 8

Earnings call

Q2 2022 earnings call

Aug 8

Current report 8-K

Financial results

Jun 28

Current report 8-K/A Events of Apr 14

Current report

Jun 17

Current report 8-K Events of Jun 14

Shareholder vote results

May 10

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $203.33M ▲ 26.7% Net income $12.29M ▲ 637.0% Diluted EPS $0.03

May 9

Earnings call

Q1 2022 earnings call

May 9

Current report 8-K Events of May 3

Director or officer change, or executive pay

May 9

Current report 8-K

Financial results

Apr 27

Proxy statement DEF 14A Meeting Jun 14, 2022

Proxy statement

Apr 27

Proxy statement DEFA14A

Proxy statement

Apr 25

Current report 8-K Events of Apr 20

Director or officer change, or executive pay

Apr 15

Current report 8-K Events of Apr 14

Completed an acquisition or sale of assets

Mar 7

Current report 8-K Events of Mar 6

Entered into a material agreement, Regulation FD disclosure

Mar 1

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $745.42M ▲ 35.4% Net loss $25.25M Diluted EPS -$0.06

Feb 28

Current report 8-K

Financial results

Feb 28

Earnings call

Q4 2021 earnings call

Feb 28

Current report 8-K

Other events

Nov 12

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $195.1M ▲ 38.9% Net loss $18.07M Diluted EPS -$0.04

Nov 10

Earnings call

Q3 2021 earnings call

Nov 10

Current report 8-K

Financial results

Aug 12

Earnings call

Q2 2021 earnings call

Aug 12

Current report 8-K

Financial results

Aug 12

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $176.64M ▲ 43.3% Net income $31.06M ▲ 13.6% Diluted EPS $0.07 ▼ 12.5%

Jun 15

Current report 8-K Events of Jun 10

Shareholder vote results

May 14

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $160.43M ▲ 20.3% Net income $1.67M ▼ 93.9% Diluted EPS $0.00

May 13

Earnings call

Q1 2021 earnings call

May 13

Current report 8-K

Financial results

Apr 27

Proxy statement DEF 14A Meeting Jun 10, 2021

Proxy statement

Apr 27

Proxy statement DEFA14A

Proxy statement

Mar 12

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $550.7M ▲ 41.9% Net loss $293.62M Diluted EPS -$1.07

Mar 11

Current report 8-K

Financial results

Dec 21

Current report 8-K Events of Dec 17

Unregistered sale of equity

Nov 12

Earnings call

Q3 2020 earnings call

Nov 12

Current report 8-K

Financial results

Nov 12

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Revenue $140.45M ▲ 38.0% Net loss $50.03M Diluted EPS -$0.21

Nov 3

Current report 8-K Events of Oct 30

Director or officer change, or executive pay

Sep 28

Current report 8-K Events of Sep 22

Entered into a material agreement, Charter or bylaw amendment, or fiscal year change

Sep 22

Registration statement S-1/A

Registration statement

Sep 14

Registration statement S-1/A

Registration statement

Aug 28

Registration statement S-1

Registration statement